Advertisement
U.S. markets closed
Advertisement

Summit Therapeutics Inc. (SMMT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.1300+0.1000 (+4.93%)
At close: 04:00PM EST
2.1300 0.00 (0.00%)
After hours: 07:31PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
705
1,809
860
Operating Expense
64,313
64,283
87,995
53,194
Operating Income
-64,313
-63,578
-86,186
-52,334
Net Non Operating Interest Income Expense
-8,440
-4,401
-281
-251
Other Income Expense
-524,794
-10,760
-2,416
-576
Pretax Income
-597,590
-78,782
-88,602
-52,910
Tax Provision
-
-
0
-213
Net Income Common Stockholders
-597,590
-78,782
-88,602
-52,697
Diluted NI Available to Com Stockholders
-597,590
-78,782
-88,602
-52,697
Basic EPS
-1.17
-0.41
-0.67
-0.76
Diluted EPS
-1.17
-0.41
-0.67
-0.76
Basic Average Shares
392,701
193,336
131,714
69,524
Diluted Average Shares
392,701
193,336
131,714
69,524
Total Operating Income as Reported
-593,739
-72,089
-86,186
-53,193
Total Expenses
64,313
64,283
87,995
53,194
Net Income from Continuing & Discontinued Operation
-597,590
-78,782
-88,602
-52,697
Normalized Income
-72,655
-67,718
-88,602
-51,841
Interest Income
-
-
0
4
Interest Expense
16,468
4,401
281
255
Net Interest Income
-8,440
-4,401
-281
-251
EBIT
-581,122
-74,381
-86,186
-52,334
EBITDA
-579,081
-71,867
-86,186
-52,334
Reconciled Depreciation
2,041
2,514
2,455
2,003
Net Income from Continuing Operation Net Minority Interest
-597,590
-78,782
-88,602
-52,697
Total Unusual Items Excluding Goodwill
-524,935
-11,064
0
-859
Total Unusual Items
-524,935
-11,064
0
-859
Normalized EBITDA
-54,146
-60,803
-86,186
-51,475
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-3.4581